![TransferGo raises $10M to expand its remittance business in Asia, doubling valuation](https://www.seventure.fr/wp-content/uploads/2022/10/systeme-protection-numerique-securite-con-322x211.jpg)
All
![Tubulis Closes Upsized €128 Million Series B2 to Accelerate Clinical Development of Solid Tumor-Focused ADC Pipeline](https://www.seventure.fr/wp-content/uploads/2020/07/10_104270789-322x211.jpg)
Tubulis Closes Upsized €128 Million Series B2 to Accelerate Clinical Development of Solid Tumor-Focused ADC Pipeline
Tubulis announced the successful completion of an upsized and oversubscribed €128 million ($138.8 million) Series B2 financing.
![BlueTech Inalve announces the closing of a €4.7 million financing round](https://www.seventure.fr/wp-content/uploads/2020/07/10_104270789-322x211.jpg)
BlueTech Inalve announces the closing of a €4.7 million financing round
The participation of the Blue Forward FundTM, managed by Seventure Partners, and the PSIM fund, managed by Bpifrance on behalf of the French government, confirms the strong...
![Siolta Therapeutics Raises $12 Million in Series C Financing for Clinical Development](https://www.seventure.fr/wp-content/uploads/2020/07/10_104270789-322x211.jpg)
Siolta Therapeutics Raises $12 Million in Series C Financing for Clinical Development
The company, has announced the completion of a $12 million Series C financing round. The round, co-led by SymBiosis and Khosla Ventures, reflects enthusiasm for Siolta's...
![Les Assises: Zurich Resilience Solutions announces the launch of “Quantification as a Service”, powered by Citalid](https://www.seventure.fr/wp-content/uploads/2022/10/systeme-protection-numerique-securite-con-322x211.jpg)
Les Assises: Zurich Resilience Solutions announces the launch of “Quantification as a Service”, powered by Citalid
Julien Chamonal, Chief Revenue Officer at Citalid, and Vivien Bilquez, Principal Cyber Risk Engineer at Zurich Insurance, co-hosted a presentation titled Cyber Insurance:...
![Pharma announces positive outcome following DSMB review reinforcing confidence in phase 3 on-going trial.](https://www.seventure.fr/wp-content/uploads/2019/02/4__104270789-322x211.jpg)
Pharma announces positive outcome following DSMB review reinforcing confidence in phase 3 on-going trial.
Maat Pharma announces that the DSMB unanimoulsy recommended that the open-label, single arm pivotal Phase 3 clinical trial evaluating MaaT013 in acute Graft-versus-Host Disease...
![IDnow introduces fully automated identity proofing solution with CPF database checks to Brazilian gambling market](https://www.seventure.fr/wp-content/uploads/2022/10/systeme-protection-numerique-securite-con-322x211.jpg)
IDnow introduces fully automated identity proofing solution with CPF database checks to Brazilian gambling market
IDnow, a leading identity proofing platform provider, announces the integration of the Brazilian CPF database check (Cadastro de Pessoas Físicas, Register of Natural Persons)...